摘要
目的探讨螺旋形热膨胀前列腺支架(Memokath)治疗高危良性前列腺增生病人的临床疗效。方法回顾性分析南京医科大学附属老年医院2017~2018年间高危良性前列腺增生病人14例,年龄80~94岁,平均(82.0±4.5)岁。所有病人均行局麻下经尿道前列腺支架植入术。分别于术后1、3、6个月,行国际前列腺症状评分(IPSS)、最大尿流率(Qmax)、残余尿量(RUV)检查并进行对比分析。结果所有病人手术均获得成功,术后6个月IPSS评分为(10.54±2.14)分,Qmax为(10.24±3.52)mL/s,RUV为(17.23±8.43)mL。与术前比较,术后IPSS下降,Qmax水平升高,RUV减少,差异均具有统计学意义(P<0.05)。术后出现尿路刺激征2例(14.2%),间断性肉眼血尿2例(14.2%),间断性尿路感染2例(14.2%)。结论采用Memokath支架是一种安全有效的治疗高危老年前列腺增生病人的方法,但其远期效果及其并发症还需进一步观察。
Objective To investigate the clinical effect of spiral thermal expansion prostatic stent(Memokath)in the treatment of high-risk benign prostatic hyperplasia(BPH)in the elderly.Methods A retrospective analysis was performed on 14 cases of aged patients with high-risk BPH from 2017 to 2018 in Geriatric Hospital of Nanjing Medical University.All patients aged 80-94 years,with an average age of 82.0±4.5 years.All patients underwent the operations under local anesthesia.International prostate symptom score(IPSS),maximum urine flow rate(Qmax)and residual urine volume(RUV)were examined and compared 1,3 and 6 months after surgery respectively.Results The operation was successful in all the patients.Compared with those before operation,the score of IPSS decreased,the level Qmax increased and RUV decreased after operation,with statistically significant differences(P<0.05).The incidence rates of urinary tract irritation,intermittent gross hematuria and urinary tract infection was 14.2%,14.2%,14.2%,respectively.Conclusions Memokath stent is a safe and effective method for the treatment of high-risk BPH in elderly patients,but its long-term effects and complications need to be further observed.
作者
张翔翔
宋剑楠
吴烨
王久林
邱镇
张世革
ZHANG Xiang-xiang;SONG Jian-nan;WU Ye;WANG Jiu-lin;QIU Zhen;ZHANG Shi-ge(Department of Urology,Geriatric Hospital of Nanjing Medical Universtity,Nanjing 210024,China)
出处
《实用老年医学》
CAS
2019年第11期1098-1100,共3页
Practical Geriatrics
关键词
前列腺增生
前列腺支架
高危
局麻
benign prostatic hyperplasia
Memokath stent
high risk
local anesthesia
作者简介
通讯作者:张世革,Email:zsg2808@163.com。
